Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

12/10/2016 07:00

Oct 12 (Reuters)-  
             Cosmos Pharmaceutical Corp.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Aug 31, 2016        Aug 31, 2015     May 31, 2017  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales            126.58              110.33           490.00     
                 (+14.7 pct)         (+5.3 pct)       (+9.6 pct)   
  Operating          6.80                5.00            18.70     
                 (+36.1 pct)         (+14.5 pct)      (+0.3 pct)   
  Recurring          7.29                5.51            20.70     
                 (+32.3 pct)         (+16.8 pct)      (+0.0 pct)   
  Net                4.61                3.37            13.50     
                 (+36.9 pct)         (+24.2 pct)      (+8.6 pct)   
  EPS            233.08 yen          170.24 yen       681.83 yen   
  Ann Div                             65.00 yen        70.00 yen   
  -Q2 div                             30.00 yen        35.00 yen   
  -Q4 div                             35.00 yen        35.00 yen   
   
  NOTE - Cosmos Pharmaceutical Corp..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T  
  ((Tokyo Headline News Desk +813 6441 1812))